One large study found that more advanced cases of colorectal cancer had a higher likelihood of returning. For example, if participants had stage 3 colon cancer, almost 25 percent experienced a ...

Circulating tumor DNA (ctDNA) — genetic material shed from tumors into the bloodstream — may help risk-stratify patients with ...

"ESMO 2025: MSD’s ADC leapfrogs to Phase III in colorectal cancer " was originally created and published by Clinical Trials ...

IRCCS Ospedale Policlinico San Martino with Mayo Clinic and multiple international cancer research centers have delivered a pooled analysis indicating that colon cancer recurrence risk drops below 0.5 ...

Cancer rates in young people are growing, and those in the GI tract are rising fastest of all. Here are five things to know about colorectal cancer from an expert.

Colorectal cancer is the third most common cancer worldwide. It is estimated that there are over 1.5 million diagnoses a year ...

“ur finding enables the safe discontinuation of follow-up after 6 years, leading to an improvement in quality of life and a reduction in health care system costs,” study researchers wrote.

Merck KGaA could now have a head start in the race to market Precem-TcT, which could become the first widely approved ADC in ...